UK Companies House feature
AUSDIAGNOSTICS UK LIMITED
Cash
£33K
-96.4% vs 2023
Net assets
—
Equity attributable
Employees
3
-89.3% vs 2023
Profit before tax
-£572K
-176.3% vs 2023
Profile
- Company number
- 08507496
- Status
- Active
- Incorporation
- 2013-04-29
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 26600
- Hubs
- UK Healthcare
Profit before tax
6-year trend · vs UK Healthcare median
Accounts
6-year trend · latest 2024-12-31
| Metric | Trend | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | £749,430 | -£571,671 | |
| Net profit | — | — | — | — | — | — | |
| Cash | — | — | — | — | £941,821 | £33,435 | |
| Total assets less current liabilities | — | — | — | — | — | — | |
| Net assets | — | — | — | — | — | — | |
| Equity | £108,606 | £1,669,822 | £4,531,187 | £5,734,755 | £6,324,406 | £1,896,089 | |
| Average employees | — | — | — | — | 28 | 3 | |
| Wages | — | — | — | — | £1,677,710 | £157,592 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Shaw Gibbs (Audit) Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“On 8 January 2024 the company took the decision to cease trading and is working towards closing the business including selling remaining stock and dealing with property leases. The financial statements have been prepared on a basis other than going concern, including reducing assets to their recoverable amount.”
Significant events
- “After the reporting date, the Company exercised a break option in respect of its only property lease. The lease liability in these financial statements has been updated to reflect the revised lease term.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 5 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| WOOLLEY, Frank Nicholas | Secretary | 2025-04-25 | — | — |
| BEVIS, Simon James | Director | 2025-02-26 | Jun 1965 | British |
Show 5 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BEARE, Kevin Leslie | Secretary | 2013-04-29 | 2013-09-04 |
| CALZAVARA, Marco Joseph | Director | 2022-08-31 | 2024-02-05 |
| GILROY, Scott Lindsey | Director | 2022-03-03 | 2025-02-26 |
| HALE, Richard Stephen | Director | 2013-08-20 | 2021-05-24 |
| STANLEY, Keith Kendall | Director | 2013-04-29 | 2022-08-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dr. Ralf Dreher | Individual | Shares 50–75%, Voting 50–75%, Appoints directors | 2022-08-31 | Active |
| Clinical Evidence Enterprises Pty. Ltd. | Corporate entity | Shares 75–100%, Voting 75–100% | 2017-04-29 | Ceased 2022-08-31 |
Filing timeline
Last 20 of 50 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-30 | CH01 | officers | change person director company with change date |
| 2026-03-27 | AP03 | officers | appoint person secretary company with name date |
| 2025-10-28 | AA | accounts | accounts with accounts type full |
| 2025-06-11 | AD01 | address | change registered office address company with date old address new address |
| 2025-05-13 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-05-12 | CH01 | officers | change person director company with change date |
| 2025-05-12 | PSC04 | persons-with-significant-control | change to a person with significant control |
| 2025-02-28 | TM01 | officers | termination director company with name termination date |
| 2025-02-28 | AP01 | officers | appoint person director company with name date |
| 2024-05-02 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-03-27 | AA | accounts | accounts with accounts type full |
| 2024-02-05 | TM01 | officers | termination director company with name termination date |
| 2024-01-29 | AD01 | address | change registered office address company with date old address new address |
| 2024-01-29 | CH01 | officers | change person director company with change date |
| 2024-01-29 | CH01 | officers | change person director company with change date |
| 2023-06-02 | AA01 | accounts | change account reference date company current extended |
| 2023-05-12 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-11-24 | AA | accounts | accounts with accounts type full |
| 2022-10-14 | PSC04 | persons-with-significant-control | change to a person with significant control |
| 2022-10-02 | AA | accounts | accounts with accounts type full |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory